Amgen Inc. (AMGN)

Index: Nasdaq 100
0.99%
$1.85
$188.17
23:25 20/09/17
$188.17
23:25 20/09/17
DAILY VARIATION
0.99%
$1.85
VOLUME
2,683,034
DATA
52 Week High
$191.00
52 Week Low
$135.22
Shares Issued
729.67m
Market Cap
$137,302.90m
RiskGrade
92
Beta
0.97
MENU

Amgen Inc. Overview

Incorporated in 1980, Amgen is the world's largest biotechnology company engaged in the discovery, development, manufacture and marketing of human therapeutics based on advances in cellular and molecular biology. Amgen’s research and development programmes focus primarily on hematology, oncology, inflammation, neurology and metabolic disorders. In July 2002, the group acquired Immunex Corporation, a biopharmaceutical company dedicated to developing immune system science to protect human health.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 2.1% 2.4%
Div Cover 2.6 2.8
Op Mrgn 42.6% 50.0%
ROCE 23.2%
Latest F'cast
P/E 18.2 1,492.6
PEG 1.4 0.7
Pr/Revenue 6.0 6.0
Pr/Book 4.6
Latest F'cast
Revenue 6.1% -3.9%
PBT 14.9% n/a
EPS 12.8% 0.7%
DPS 26.6% 2.2%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 17,265.00 5,009.00 561.00¢ 15.4 0.4 38% 144.00¢ 1.7%
2013-12-31 18,676.00 5,265.00 675.00¢ 16.9 0.8 20% 188.00¢ 1.6%
2014-12-31 20,063.00 5,585.00 680.00¢ 23.4 31.6 1% 244.00¢ 1.5%
2015-12-31 21,662.00 7,978.00 915.00¢ 17.7 0.5 35% 316.00¢ 1.9%
2016-12-31 22,991.00 9,163.00 1,032.00¢ 14.2 1.1 13% 400.00¢ 2.7%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 22,830.17 11,414.30 1,256.14c 1,492.6 68.7 22% 454.69c 2.4%
2018-12-31 23,083.63 11,625.04 1,284.05c 1,454.1 654.4 2% 493.59c 2.6%

Regulatory News

No results found

Newspaper Links

No results found